{"DataElement":{"publicId":"7652563","version":"1","preferredName":"Chronic Graft Versus Host Disease Overall Severity Clinician Assessment Type","preferredDefinition":"A description of the clinician assessment of the overall severity of chronic graft versus host disease.","longName":"7652562v1.0:2795869v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7652562","version":"1","preferredName":"Chronic Graft Versus Host Disease Overall Severity Clinician Assessment","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation._Including everything._Severity; used of the degree of something undesirable e.g. pain or weather._An individual, such as a physician or nurse practitioner, who takes responsibility for a patient's care during an encounter._The final result of a determination of the value, significance, or extent of.","longName":"2512832v1.0:7652560v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512832","version":"1","preferredName":"Chronic Graft Versus Host Disease","preferredDefinition":"A graft versus host disease with symptoms appearing more than 100 days post-transplant.","longName":"C4981","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8985BC-2113-374B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7652560","version":"1","preferredName":"Overall Severity Clinician Assessment","preferredDefinition":"Including everything.:Severity; used of the degree of something undesirable e.g. pain or weather.:An individual, such as a physician or nurse practitioner, who takes responsibility for a patient's care during an encounter.:The final result of a determination of the value, significance, or extent of.","longName":"C25605:C25676:C85499:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinician","conceptCode":"C85499","definition":"An individual, such as a physician or nurse practitioner, who takes responsibility for a patient's care during an encounter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1AD68DF-F83B-04DA-E053-4EBD850AB0B3","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1AD68DF-F84C-04DA-E053-4EBD850AB0B3","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-05-06","modifiedBy":"MALUMK","dateModified":"2021-11-02","changeDescription":"Released. 11/02/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2795869","version":"1","preferredName":"Graft Versus Host Disease Severity Type","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Used of the degree of something undesirable e.g. pain or weather; also, strictness._Type; a subdivision of a particular kind of thing.","longName":"GVHD_SV_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Severe","valueDescription":"Severe","ValueMeaning":{"publicId":"2955376","version":"1","preferredName":"Severe","longName":"2955376","preferredDefinition":"Signs and symptoms of chronic GVHD limit function substantially despite appropriate therapy or are progressive through second line therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"767278B8-77EB-4D95-E040-BB89AD4364D6","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"767278B8-7803-4D95-E040-BB89AD4364D6","beginDate":"2008-10-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","deletedIndicator":"No"},{"value":"Mild","valueDescription":"Mild","ValueMeaning":{"publicId":"2955374","version":"1","preferredName":"Mild","longName":"2955374","preferredDefinition":"Signs and symptoms of chronic GVHD do not interfere substantially with function and do not progress once appropriately treated with local therapy or standard systemic therapy (corticosteroids and/or cyclosporine or FK 506)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"767278B8-77A7-4D95-E040-BB89AD4364D6","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"767278B8-77BF-4D95-E040-BB89AD4364D6","beginDate":"2008-10-31","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","deletedIndicator":"No"},{"value":"Moderate","valueDescription":"Moderate","ValueMeaning":{"publicId":"2955375","version":"1","preferredName":"Moderate","longName":"2955375","preferredDefinition":"Signs and symptoms of chronic GVHD interfere somewhat with function despite appropriate therapy or are progressive through first line systemic therapy (corticosteroids and/or cyclosporine or FK 506)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"767278B8-77C9-4D95-E040-BB89AD4364D6","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"767278B8-77E1-4D95-E040-BB89AD4364D6","beginDate":"2008-10-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","deletedIndicator":"No"},{"value":"No GVHD","valueDescription":"Negation Graft Versus Host Disease","ValueMeaning":{"publicId":"5580503","version":"1","preferredName":"Negation Graft Versus Host Disease","longName":"5580503","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41D13E08-B33D-2E95-E053-F662850ACE8B","latestVersionIndicator":"Yes","beginDate":"2016-11-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"41D13E08-B356-2E95-E053-F662850ACE8B","beginDate":"2016-11-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-21","modifiedBy":"ONEDATA","dateModified":"2016-11-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2795868","version":"1","preferredName":"Graft Versus Host Disease Severity Type","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.:Severity; used of the degree of something undesirable e.g. pain or weather.:Type; a subdivision of a particular kind of thing.","longName":"C3063:C25676:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A670340-59A4-1796-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"ONEDATA","dateModified":"2008-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A670340-59B5-1796-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"CCURATOR","dateModified":"2023-12-21","changeDescription":". Added PV &#34;No GVHD&#34; for MC. AK 11/21/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the clinician assess","type":"Preferred Question Text","description":"What was the clinician assessment of the overall severity of chronic GVHD?","url":null,"context":"NHLBI"},{"name":"Subjective Clinician Opinion of Severity","type":"Application Standard Question Text","description":"Subjective Clinician Opinion of Severity","url":null,"context":"NHLBI"},{"name":"Subjective Clinician Opinion of Severity","type":"Alternate Question Text","description":"Subjective Clinician Opinion of Severity","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1AF3543-4091-2865-E053-4EBD850A5DA7","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-05-06","modifiedBy":"MALUMK","dateModified":"2021-11-02","changeDescription":"Released. 11/02/2021 KMM; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}